Pipeline
Clinical Development Pipeline
| Rights | Modality | Target/molecule | Pre-Clinical | IND | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|---|---|---|
| China | JL14002 Biosimilar | VEGF-A | |||||
| China | GPN02006 Radionuclide | GPC3 | |||||
| Global | JL18008 Fusion protein | IL-7/HSA | |||||
| Global | JL19001 Fusion protein | IL-15/HSA | |||||
| Global | JLM019 Fusion protein | CD80/PD-1 | |||||
| Global | JLM066 Fusion protein | BAFF/APRIL | |||||
| Global | JLF048 T-cell engager | EGFR/CD3 | |||||
| Global | JLF025 T-cell engager | MSLN/CD3 | |||||
| Global | JLC056 ADC | TF/EGFR | |||||
| Global | JLC059 ADC | GPC3/PD-L1 | |||||
| Global | JLC062 ADC | B7H3/PD-L1 | |||||